List of works - James Lilleker

A missense mutation in DYNC1H1 gene causing spinal muscular atrophy - Lower extremity, dominant.

scientific article published on 14 December 2017

Advances in the early diagnosis and therapy of inclusion body myositis

scientific article published on 01 November 2018

Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

scientific article

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

scientific article published on 25 January 2017

Fibrous myopathy induced by intramuscular injections of cyclizine

scientific article published on 11 May 2020

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

scientific article published on 13 April 2019

Genetics in inclusion body myositis.

scientific article published on August 2017

Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications

scientific article

Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment

scientific article published on 01 July 2017

Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum

scientific article published on 13 January 2017

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria

scientific article published on 01 December 2019

Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians

scientific article published on 02 September 2020

Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results

scientific article published on 20 July 2020

Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups

scientific article published on 05 March 2020

Metabolic myopathies: a practical approach

scientific article published on 9 December 2017

Missense mutation in the ITPR1 gene presenting with ataxic cerebral palsy: Description of an affected family and literature review

scientific article published on 8 July 2017

Neurogenic pulmonary oedema complicating a lateral medullary infarct

scientific article published on 26 July 2018

Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study

scientific article published on 18 December 2013

Paroxysmal dysarthria ataxia syndrome responds to lacosamide

scientific article published on 19 August 2014

Patient-centred standards of care for adults with myositis

scientific article published on 28 November 2017

Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS—A multicentre case–control study

scientific article published on 27 January 2025

Prophylactic anticoagulation in Guillain-Barré syndrome: too much of a good thing?

scientific article published on 17 July 2015

Rapamycin for inclusion body myositis: targeting non-inflammatory mechanisms

scientific article published on 01 March 2019

Respiratory failure in clustered acetylcholine receptor autoantibody-positive myasthenia gravis

scientific article published on 09 July 2019

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.

scientific article published on 19 December 2017

Selected aspects of the current management of myositis

scientific article

The EuroMyositis registry: an international collaborative tool to facilitate myositis research.

scientific article published on 30 August 2017

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.

scientific article published in March 2019

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies

scientific article published on 01 October 2016

Transient focal leukoencephalopathy with cerebral oedema as a presentation of cerebral amyloid angiopathy

scientific article published on 01 June 2016

Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies.

scientific article published on 12 March 2018

VGKC complex antibodies in epilepsy: Diagnostic yield and therapeutic implications ⬇️

scientific article published on July 7, 2013

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis

scientific article published on 13 February 2019

List of works by James Lilleker

A missense mutation in DYNC1H1 gene causing spinal muscular atrophy - Lower extremity, dominant.

Advances in the early diagnosis and therapy of inclusion body myositis

Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.

Fibrous myopathy induced by intramuscular injections of cyclizine

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

Genetics in inclusion body myositis.

Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications

Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment

Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria

Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians

Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results

Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups

Metabolic myopathies: a practical approach

Missense mutation in the ITPR1 gene presenting with ataxic cerebral palsy: Description of an affected family and literature review

Neurogenic pulmonary oedema complicating a lateral medullary infarct

Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study

Paroxysmal dysarthria ataxia syndrome responds to lacosamide

Patient-centred standards of care for adults with myositis

Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS—A multicentre case–control study

Prophylactic anticoagulation in Guillain-Barré syndrome: too much of a good thing?

Rapamycin for inclusion body myositis: targeting non-inflammatory mechanisms

Respiratory failure in clustered acetylcholine receptor autoantibody-positive myasthenia gravis

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.

Selected aspects of the current management of myositis

The EuroMyositis registry: an international collaborative tool to facilitate myositis research.

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies

Transient focal leukoencephalopathy with cerebral oedema as a presentation of cerebral amyloid angiopathy

Using serum troponins to screen for cardiac involvement and assess disease activity in the idiopathic inflammatory myopathies.

VGKC complex antibodies in epilepsy: Diagnostic yield and therapeutic implications ⬇️

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis